Name | Bioventix |
---|---|
Epic | BVXP |
Isin | GB00B4QVDF07 |
Index | MID300 |
Industry | Pharmaceuticals & Biotechnology |
Latest share price | 3,700.00p | Net gearing | n/a |
---|---|---|---|
Market capitalisation | £193.13 | Debt ratio | n/a |
Shares in issue | 5.22 | Debt-to-equity ratio | n/a |
P/E ratio | 24 | Assets / equity ratio | n/a |
Total dividends per share | 68.00p | Price to book value | n/a |
Dividend yield | 3.9 | ROCE | n/a |
Dividend cover | 1.06 | EPS growth | 9 |
Earning per share | 160.63 | 52-week high / low | 3,225.00p / 5,060.00p |
Type | Ex-date | Pay-date | Net-dividend |
---|---|---|---|
1st Interim | 2024-04-11 | 2024-04-26 | 68.00p |
2nd Interim | 2023-11-09 | 2023-11-24 | 90.00p |
1st Interim | 2023-04-06 | 2023-04-21 | 62.00p |
Special | 2022-11-03 | 2022-11-18 | 26.00p |
2nd Interim | 2022-11-03 | 2022-11-18 | 74.00p |
1st Interim | 2022-04-07 | 2022-04-22 | 52.00p |
Special | 2021-10-28 | 2021-11-12 | 38.00p |
2nd Interim | 2021-10-28 | 2021-11-12 | 62.00p |
1st Interim | 2021-04-08 | 2021-04-23 | 43.00p |
Company name | Bioventix |
---|---|
Address | 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH |
Telephone | |
Website | http://www.bioventix.com |
Director | Position |
---|---|
Mr Peter John Harrison | CEO |
Mr Bruce Hiscock | CFO |
Mr Ian James Nicholson | Chairman |
Mr Nicholas (Nick) John McCooke | Independent Non-Executive Director |
Mr Joanne (Jo) Pisani | Independent Non-Executive Director |
Assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Reporting date | 30/06/23 | 30/06/22 | 30/06/21 |
Intangible asssets and goodwill | n/a | n/a | n/a |
Investments and other non-current assets | 0.61 | 0.61 | 0.61 |
Total non-current assets | 1.19 | 1.3 | 1.45 |
Inventory / work in progress | 0.57 | 0.46 | 0.33 |
Trade and other receivables | 5.81 | 5.22 | 4.63 |
Cash and equivalents | 5.72 | 6.13 | 6.49 |
Other current assets and asset held for resale | n/a | n/a | n/a |
Total of all assets | 13.28 | 13.12 | 12.91 |
Liabilities £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Short term liabilities | 1.2 | 1.25 | 1.01 |
Long term liabilities | 0.02 | 0.04 | 0.08 |
Other liabilites / pension etc | n/a | n/a | n/a |
Total of all liabilities | 1.22 | 1.3 | 1.09 |
Net assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Net assets | 12.06 | 11.82 | 11.82 |
Equity £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Share capital | 0.26 | 0.26 | 0.26 |
Minority interests | n/a | n/a | n/a |
Retained earnings | 10.33 | 10.23 | 10.23 |
Share premium account | 1.47 | 1.33 | 1.33 |
Total equity | 12.06 | 11.82 | 11.82 |
Income £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | n/a | n/a | n/a |
Operating profit | 10.03 | 9.27 | 8.09 |
Pre-tax profit | 10.13 | 9.28 | 8.12 |